KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Organon (OGN) Cost of Revenue (2020 - 2025)

Historic Cost of Revenue for Organon (OGN) over the last 6 years, with Q3 2025 value amounting to $745.0 million.

  • Organon's Cost of Revenue rose 1305.01% to $745.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.8 billion, marking a year-over-year increase of 590.65%. This contributed to the annual value of $2.7 billion for FY2024, which is 687.87% up from last year.
  • Latest data reveals that Organon reported Cost of Revenue of $745.0 million as of Q3 2025, which was up 1305.01% from $720.0 million recorded in Q2 2025.
  • In the past 5 years, Organon's Cost of Revenue registered a high of $745.0 million during Q3 2025, and its lowest value of $551.0 million during Q3 2022.
  • In the last 5 years, Organon's Cost of Revenue had a median value of $612.0 million in 2023 and averaged $632.4 million.
  • As far as peak fluctuations go, Organon's Cost of Revenue skyrocketed by 2673.91% in 2021, and later plummeted by 952.38% in 2022.
  • Organon's Cost of Revenue (Quarter) stood at $599.0 million in 2021, then dropped by 0.83% to $594.0 million in 2022, then increased by 14.98% to $683.0 million in 2023, then increased by 1.9% to $696.0 million in 2024, then grew by 7.04% to $745.0 million in 2025.
  • Its Cost of Revenue stands at $745.0 million for Q3 2025, versus $720.0 million for Q2 2025 and $672.0 million for Q1 2025.